Literature DB >> 17284646

Editorial: Calcitonin determination in patients with nodular thyroid disease.

I Borget, G De Pouvourville, M Schlumberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17284646     DOI： 10.1210/jc.2006-2735

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  12 in total

1.  Early diagnosis of medullary thyroid carcinoma: is systematic calcitonin screening appropriate in patients with nodular thyroid disease?

Authors:  Giuseppe Costante; Sebastiano Filetti
Journal:  Oncologist       Date:  2011-01-06

Review 2.  Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls.

Authors:  Giuseppe Costante; Cosimo Durante; Zélia Francis; Martin Schlumberger; Sebastiano Filetti
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-01

Review 3.  [Calcitonin determination for early diagnosis of medullary thyroid cancer].

Authors:  W Karges
Journal:  Chirurg       Date:  2010-07       Impact factor: 0.955

4.  Measurement of calcitonin and calcitonin gene-related peptide mRNA refines the management of patients with medullary thyroid cancer and may replace calcitonin-stimulation tests.

Authors:  Cléber P Camacho; Susan C Lindsey; Maria Clara C Melo; Ji H Yang; Fausto Germano-Neto; Flávia de O F Valente; Thiago R N Lima; Rosa Paula M Biscolla; José G H Vieira; Janete M Cerutti; Magnus R Dias-da-Silva; Rui M B Maciel
Journal:  Thyroid       Date:  2013-03       Impact factor: 6.568

5.  Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.

Authors:  Hans Hg Verbeek; Jan Willem B de Groot; Wim J Sluiter; Anneke C Muller Kobold; Edwin R van den Heuvel; John Tm Plukker; Thera P Links
Journal:  Cochrane Database Syst Rev       Date:  2020-03-16

6.  Calcitonin Screening in Nodular Thyroid Disease: Is There a Definitive Answer?

Authors:  Catarina Silvestre; Joaquim Sampaio Matias; Helena Proença; Maria João Bugalho
Journal:  Eur Thyroid J       Date:  2018-12-05

Review 7.  Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma.

Authors:  Sergio P A Toledo; Delmar M Lourenço; Marcelo Augusto Santos; Marcos R Tavares; Rodrigo A Toledo; Joya Emilie de Menezes Correia-Deur
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

8.  Sporadic medullary thyroid carcinoma: clinical data from a university hospital.

Authors:  Joya Emilie M Correia-Deur; Rodrigo A Toledo; Alice T Imazawa; Delmar M Lourenço; Marilza C L Ezabella; Marcos R Tavares; Sergio P A Toledo
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

9.  False positive results using calcitonin as a screening method for medullary thyroid carcinoma.

Authors:  Rafael Loch Batista; Andrea Cecilia Toscanini; Lenine Garcia Brandão; Malebranche Berardo C Cunha-Neto
Journal:  Indian J Endocrinol Metab       Date:  2013-05

10.  Patients with papillary thyroid carcinoma associated with high stimulated serum calcitonin levels.

Authors:  Kursad Unluhizarci; Hulya Akgun; Bahadır Oz; Zuleyha Karaca; Fatih Tanriverdi; Fahrettin Kelestimur
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.